Liście morwy jako źródło naturalnych substancji biologicznie aktywnych

1. Srivastava S, Kapoor R, Thathola A i wsp. Mulberry ( Morus alba) leaves as human food: a new dimension of sericulture. Int J Food Sci Nutr 2003; 54:411-6. 2. Bown D. Encyclopedia of herbs and their uses, London: Dorling Kindersley; 1995. p. 313-4. 3. Butt MS, Nazir A, Sultan T. i wsp. Morus alba L. nature´s functional tonic, Trends Food Sci Technol 2008; 19:505-12. 4. Seneta W, Dolatowski J. Dendrologia. Warszawa: Wydawnictwa Naukowe PWN; 2007. 5. Bose PC. Genetic resources of mulberry and utilization. Mysore, India: CSR and TI; 1989. p.183-90. 6. Jeszka M, Flaczyk E. HPLC analysis – determination of flavonols in Morus alba leaves. Materiały konferencyjne: III. International Scientific Conference of PhD. Students, Faculty of Biotechnology and Food Sciences and Faculty of Agrobiology and Food Resources at Slovak University of Agriculture in Nitra, 28th November 2008. p.118-20. 7. Srivastava S, Kapoor R, Thathola A. Nutritional quality of leaves of some genotypes of mulberry ( Morus alba). Int J Food Sci Nutr 2006; 57:305-13. 8. Yen GC, Wu S, Duh PD. Extraction and identification of antioxidant components from the leaves of mulberry ( Morus alba L.). J Agric Food Chem 1996; 44:1687-90. 9. Doi K, Kojima T, Makino M i wsp. Studies on the constituents of the leaves of Morus alba L. Chemical Pharmacol Bull 2001; 49:151-3. 10. Enkhmaa B, Shiwaku K, Katsube T i wsp. Mulberry ( Morus alba L.) leaves and their major flavonol quercetin 3-(6-malonylglucoside) attenuate atherosclerotic lesion development in LDL receptor-deficient mice. J Nutrition 2005; 135:729-34. 11. Katsube T, Imawaka N, Kawano Y i wsp. Antioxidant flavonol glycosides in mulberry ( Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chem 2006; 97(1):25-31. 12. Kim SY, Gao JJ, Lee, WC. Antioxidative flavonoids from the leaves of Morus alba. Arch Pharm 1999; 22:81-5. 13. Onogi A, Osawa K, Yasuda H i wsp. Flavonol glycosides from the leaves of Morus alba L. Shoyakugaku Zasshi 1993; 47:423-5. 14. Asano N, Yamashita T, Yasuda K i wsp. Polyhydroxylated alkaloids isolated from mulberry trees ( Morus alba L.) and silkworms ( Bombyx mori L.). J Agric Food Chem 2001; 49:4208-13. 15. Chen FJ, Nakashima N, Kimura I i wsp. Potentiating effects on pilocarpine-induced saliva secretion, by extracts and N-containing sugars derived from mulberry leaves, in streptozocin-diabetic mice. Biol Pharm Bull 1995; 18(12):1676-80. 16. Liu H, Qiu N, Ding H i wsp. Polyphenols contents and antioxidant capacity of 68 Chinese herbals suitable for medical or food uses. Food Res Int 2008; 41:363-70. 17. Katsube T, Tsurunaga Y, Sugiyama M i wsp. Effect of air-drying temperature on antioxidant capacity and stability of polyphenolic compounds in mulberry ( Morus alba L.) leaves. Food Chem 2009; 113:964-9. 18. Sastri BN. The wealth of India, raw materials. New Delhi, India: Council of Scientific and Industrial Research; 1962. p.429-39. 19. Arabshahi-Delouee S, Urooj A. Antioxidant properties of various solvent extracts of mulberry ( Morus indica L.) leaves. Food Chem 2007; 102:1233-40. 20. Doi K, Kojima T, Fujimoto Y. Mulberry leaf extract inhibits oxidative modification of rabbit and human low-density lipoprotein. Biol Pharm Bull 2000; 23:1066-71. 21. Lee SH, Choi SY, Kim H. Mulberroside F isolated from the leaves of Morus alba inhibits melanin biosynthesis. Biol Pharm Bull 2002; 25:1045-8. 22. Chen J, Li X. Hypolipidemic effect of flavonoids from mulberry leaves in triton WR-1339 induced hyperlipidemic mice. Asia Pac J Clin Nutr 2007; 16:290-4. 23. Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects in superoxide radicals. Food Chem 1999; 64:555-9. 24. Wattanapitayakul SK, Chularojmontri L, Herunsalee A i wsp. Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin Pharm Toxicol 2005; 96:80-7. 25. Choi EM, Hwang JK. Effects of Morus alba leaf extract on the production of nitric oxide prostaglandin E2 and cytokines in RAW264.7 macrophages. Fitoterapia 2005; 76:608-13. 26. Chai OH, Lee MS, Han EH i wsp. Inhibitory effects of Morus alba on compound 48/80-induced anaphylactic reactions and anti-chicken gamma globulin IgE mediated mast cell activation. Biol Pharm Bull 2005; 28:1852-8. 27. Harauma A, Murayama T, Ikeyama K i wsp. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice. Biochem Biophys Res Commun 2007; 358:751-6. 28. Niidome T, Takahashi K, Goto Y i wsp. Mulberry leaf extract prevents amyloid beta-peptide fibryl formation and neurotoxicity. Neuroreport 2007; 18:813-6. 29. Tierney LM, McPhee SJ, Papadakis MA. Current medical diagnosis and treatment: International edition. New York: Lange Medical Books/McGraw-Hill; 2002. 30. Nuengchamnong N, Ingkaninan K, Kaewruang W i wsp. Quantitative determination of 1-deoxynojirimycin in mulberry leaves using liquid chromatography etandem mass spectrometry. J Pharm Biomed Anal 2007; 44:853-8. 31. Rosołowska-Huszcz D. Antyoksydanty w profilaktyce i terapii cukrzycy typu 2. Żywność Nauka Technologia Jakość 2007; 6(55):62-70. 32. Musabayane CT, Bwititi PT, Ojewole JA. Effects of oral administration of some herbal extracts on food consumption and blood glucose levels in normal and streptozotocin-treated diabetic rats. Methods Find Exp Clin Pharmacol 2006; 28:223-8. 33. Oku T, Yamada M, Nakamura M i wsp. Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. Br J Nutr 2006; 95:933-8. 34. Syvacy A, Sokmen M. Seasonal changes in antioxidant activity total phenolic and anthocyanin constituent of the stems of two Morus species ( Morus alba L. and Morus nigra L.). Plant Growth Regulation 2004; 44:251-6. 35. Kimura T, Nakagawa K, Kubota H i wsp. Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem 2007; 55(14):5869-74. 36. Hansawasdi C, Kawabata J. Alpha-glucosidase inhibitory effect of mulberry ( Morus alba) leaves on Caco-2. Fitoterapia 2006; 77:568-73. 37. Mudra M, Ercan-Fang N, Zhong L. Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects. Diabetes Care 2007; 30(5):1272-4. 38. Lee J, Chae K, Ha J i wsp. Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis and Artemisia capillaris in high-fat diet-induced obese mice. J Ethnopharmacol 2008; 115:263-70. 39. Oh KS, Ryu, SY, Lee S i wsp. Melanin-concentrating hormone-1 receptor antagonism and anti-obesity effects of ethanolic extract from Morus alba leaves in diet-induced obese mice. J Ethnopharmacol 2009; 122:216-20. 40. Iozumi K, Hoganson GE, Pennella R i wsp. Role of tyrosinase as the determinant of pigmentation in cultured human melanocytes. J Invest Dermatol 1993; 100:806-11. 41. Khan KM, Maharvi GM, Abbaskhan A i wsp. Three tyrosinase inhibitors and antioxidant compounds from Salsola foetida. Helv Chim Acta 2003; 86:457-64. 42. Andallu B, Varadacharyulu NC. Antioxidant role of mulberry ( Morus indica L. cv. Anantha) leaves in streptozotocin-diabetic rats. Clin Chim Acta 2003; 338:3-10. 43. Fang SH, Hou YC, Chao PD. Pharmacokinetic and pharmacodynamic interactions of morin and cyclosporine. Toxicol Appl Pharmacol 2005; 205:65-70. 44. Harborne SB, Baxter H. Phytochemical dictionary. In: A handbook of bioactive compounds from plants. London: Taylor and Francis; 1995. 45. Ahmad I, Beg A. Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens. J Ethnopharmacol 2001; 74:113-23. 46. Fukai T, Kaitou K, Terad S. Antimicrobial activity of 2-arylbenzofurans from Morus species against methicillin-resistant Staphylococcus aureus. Fitoterapia 2005; 76:708-11. 47. Ono K, Nakane H, Fukushima M i wsp. Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Eur J Biochem 1990; 190(3):469-78. 48. Ratner L, Heyden NV. Mechanism of action of N-butyl deoxynojirimycin in inhibiting HIV-1 infection and activity in combination with nucleoside analogs. AIDS Res Hum Retroviruses 1993; 9(4):291-7. 49. Watson AA, Fleet GWJ, Asano N i wsp. Polyhydroxylated alkaloids – natural occurrence and therapeutic applications. Phytochemistry 2001; 56(3):265-95.